Literature DB >> 19661960

Hepatic expression of cell death-inducing DFFA-like effector C in obese subjects is reduced by marked weight loss.

Angela M Hall1, Elizabeth M Brunt, Samuel Klein, Brian N Finck.   

Abstract

The hepatic expression of the cell death-inducing DNA fragmentation factor A-like effector family (CIDEA, CIDEB, and CIDEC) genes is markedly upregulated in mouse models of obesity. We evaluated the expression of CIDE genes in liver of obese human subjects undergoing gastric bypass surgery (GBS), at the time of surgery and again 1 year later when subjects had lost 37.6 +/- 1.4% of their initial body weight. At the time of GBS, the expression of CIDEA (r(2) = 0.20, P = 0.04) and CIDEC (r(2) = 0.32, P = 0.01) was strongly correlated with BMI, whereas CIDEB was not (r(2) = 0.01, P = 0.81). One year after surgery, CIDEC expression had declined over 60% (P = 0.02), whereas CIDEA expression did not change (P = 0.20). These data demonstrate that, consistent with previous studies conducted in rodents, hepatic expression of CIDEA and CIDEC, but not CIDEB, is increased in obese humans. Moreover, the hepatic expression of CIDEC is downregulated by marked weight loss.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19661960      PMCID: PMC2957480          DOI: 10.1038/oby.2009.236

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  9 in total

1.  CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor.

Authors:  N Inohara; T Koseki; S Chen; X Wu; G Núñez
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

Review 2.  Steatohepatitis in obese individuals.

Authors:  Wael I Youssef; Arthur J McCullough
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-10       Impact factor: 3.043

3.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

4.  Fat-specific protein 27, a novel lipid droplet protein that enhances triglyceride storage.

Authors:  Vishwajeet Puri; Silvana Konda; Srijana Ranjit; Myriam Aouadi; Anil Chawla; My Chouinard; Abhijit Chakladar; Michael P Czech
Journal:  J Biol Chem       Date:  2007-09-19       Impact factor: 5.157

5.  Cidea is associated with lipid droplets and insulin sensitivity in humans.

Authors:  Vishwajeet Puri; Srijana Ranjit; Silvana Konda; Sarah M C Nicoloro; Juerg Straubhaar; Anil Chawla; My Chouinard; Chenyi Lin; Alison Burkart; Silvia Corvera; Richard A Perugini; Michael P Czech
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-28       Impact factor: 11.205

6.  Assessment of fat-specific protein 27 in the adipocyte lineage suggests a dual role for FSP27 in adipocyte metabolism and cell death.

Authors:  Ji Young Kim; Kun Liu; Shengli Zhou; Kristin Tillison; Yu Wu; Cynthia M Smas
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-01-15       Impact factor: 4.310

7.  Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation.

Authors:  John Zhong Li; Jing Ye; Bofu Xue; Jingzhong Qi; Jing Zhang; Zhihong Zhou; Qing Li; Zilong Wen; Peng Li
Journal:  Diabetes       Date:  2007-07-23       Impact factor: 9.461

8.  Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27.

Authors:  Kimihiko Matsusue; Takashi Kusakabe; Takahiro Noguchi; Shouichi Takiguchi; Toshimitsu Suzuki; Shigeru Yamano; Frank J Gonzalez
Journal:  Cell Metab       Date:  2008-04       Impact factor: 27.287

9.  CIDE-A is expressed in liver of old mice and in type 2 diabetic mouse liver exhibiting steatosis.

Authors:  Bruce Kelder; Keith Boyce; Andres Kriete; Ryan Clark; Darlene E Berryman; Sheila Nagatomi; Edward O List; Mark Braughler; John J Kopchick
Journal:  Comp Hepatol       Date:  2007-05-01
  9 in total
  17 in total

1.  Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver.

Authors:  Angela M Hall; Kou Kou; Zhouji Chen; Terri A Pietka; Mrudula Kumar; Kevin M Korenblat; Kyuha Lee; Kay Ahn; Elisa Fabbrini; Samuel Klein; Bryan Goodwin; Brian N Finck
Journal:  J Lipid Res       Date:  2012-03-06       Impact factor: 5.922

2.  Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.

Authors:  Ming-Jiang Xu; Yan Cai; Hua Wang; José Altamirano; Binxia Chang; Adeline Bertola; Gemma Odena; Jim Lu; Naoki Tanaka; Kimihiko Matsusue; Tsutomu Matsubara; Partha Mukhopadhyay; Shioko Kimura; Pal Pacher; Frank J Gonzalez; Ramon Bataller; Bin Gao
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

3.  CIDEC/FSP27 is regulated by peroxisome proliferator-activated receptor alpha and plays a critical role in fasting- and diet-induced hepatosteatosis.

Authors:  Cédric Langhi; Ángel Baldán
Journal:  Hepatology       Date:  2015-03-09       Impact factor: 17.425

4.  Differential Roles of Cell Death-inducing DNA Fragmentation Factor-α-like Effector (CIDE) Proteins in Promoting Lipid Droplet Fusion and Growth in Subpopulations of Hepatocytes.

Authors:  Wenyi Xu; Lizhen Wu; Miao Yu; Feng-Jung Chen; Muhammad Arshad; Xiayu Xia; Hao Ren; Jinhai Yu; Li Xu; Dijin Xu; John Zhong Li; Peng Li; Linkang Zhou
Journal:  J Biol Chem       Date:  2016-01-05       Impact factor: 5.157

5.  Expression of hepatic fat-specific protein 27 depends on the specific etiology of fatty liver.

Authors:  Daisuke Aibara; Kimihiko Matsusue; Kohei Matsuo; Soichi Takiguchi; Frank J Gonzalez; Shigeru Yamano
Journal:  Biol Pharm Bull       Date:  2013       Impact factor: 2.233

6.  Haplotypes in the promoter region of the CIDEC gene associated with growth traits in Nanyang cattle.

Authors:  Jing Wang; Liu-shuai Hua; Hong Pan; Liang-zhi Zhang; Ming-xun Li; Yong-zhen Huang; Zhuan-jian Li; Xian-yong Lan; Chu-zhao Lei; Cong-jun Li; Hong Chen
Journal:  Sci Rep       Date:  2015-07-20       Impact factor: 4.379

7.  Therapeutic silencing of fat-specific protein 27 improves glycemic control in mouse models of obesity and insulin resistance.

Authors:  Cédric Langhi; Noemí Arias; Ananthi Rajamoorthi; Jeannine Basta; Richard G Lee; Ángel Baldán
Journal:  J Lipid Res       Date:  2016-11-24       Impact factor: 5.922

8.  Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.

Authors:  Ananthi Rajamoorthi; Noemí Arias; Jeannine Basta; Richard G Lee; Ángel Baldán
Journal:  J Lipid Res       Date:  2017-09-05       Impact factor: 5.922

9.  Metabolomic study of carotid-femoral pulse-wave velocity in women.

Authors:  Cristina Menni; Massimo Mangino; Marina Cecelja; Maria Psatha; Mary J Brosnan; Jeff Trimmer; Robert P Mohney; Phil Chowienczyk; Sandosh Padmanabhan; Tim D Spector; Ana M Valdes
Journal:  J Hypertens       Date:  2015-04       Impact factor: 4.844

10.  Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver.

Authors:  Yun-Xia Zhu; Ming-Liang Zhang; Yuan Zhong; Chen Wang; Wei-Ping Jia
Journal:  J Diabetes Res       Date:  2015-12-07       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.